drugset / Trial / NCT06766916
Crisugabalin for Radiotherapy-Related Neuropathic Pain
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate whether Crisugabalin has similar efficacy compared to Pregabalin in reducing radiotherapy-related neuropathic pain (RRNP) in patients with head and neck cancers.
Timeline
- Start
- 2025-05-07
- Primary completion
- 2026-11-30
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK16149 | Unknown | 60 mg | Oral |
| Comparator | Pregabalin | Small molecule | 300 mg | Oral |